{"name":"Translate Bio, Inc.","slug":"translate-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdHZhWW9NMDBmcm4waWd3dlZJTk4tRmRPU2hCU08wSENHcVpSUVYtUDhLdVVkQWdpb2tXb0JQYzJuSFVFSkkxRnhnZ3piSzdpaV9hLVo0Ti1MVGdxUFBVWHNrSTFsYlJvX0lqUk5DVzgxY3ZHVVlKYm01dUFyMmpDWmdIMWZDa0diRk5KZjdqczdFUG5YMk1RNw?oc=5","date":"2026-03-31","type":"deal","source":"Yahoo Finance","summary":"NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development - Yahoo Finance","headline":"NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNLWpFTzhYNjJyYzdYUTYzaklaNUNpbjlVR0UxbmU4WGd5TERqb3hGVkd4bkVSbDVpRzNvSUdQQm5LNlA5aUxmUTlZRlUycGExZV84aTA5T04zMTJhUmhLTEozbkVsdmw4RFl4WDJSVjNJWGJBOTF2QXg4ell6b1ZKNXNMdmdJcUdqb3QydFFpaEd2UQ?oc=5","date":"2026-01-20","type":"pipeline","source":"BioPharma Dive","summary":"Kailera’s Ron Renaud on how a China-linked startup can compete in obesity - BioPharma Dive","headline":"Kailera’s Ron Renaud on how a China-linked startup can compete in obesity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQV19jTXRsemVuc21yOWN6emNmTTBTZ3JjWUdnWUZNU3IxRjlBZVJTZURJQ1psYWNGWXVraGZjTU96aUhQMXJnZmdXOE5fTmdNS3dxMms5bkpqZTRyWkxqZ182Mmh4Rk9oQlY4MzNRWGxPVVJSZjJLaHlfYlVfb0d6cjNudGNjdER1MnlqdS03RFI5THhHYmJfR2xrSENJTFpwTUxzbk1sT0VXUUVKcjczTFdDd2lNOHZtMHJER0hYdDhia2wtZGhZemptMA?oc=5","date":"2026-01-19","type":"patent","source":"pearceip.law","summary":"Seqirus Successfully Opposes Translate Bio’s Liposome Patent - Lessons on Support and Sufficiency - pearceip.law","headline":"Seqirus Successfully Opposes Translate Bio’s Liposome Patent - Lessons on Support and Sufficiency","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQM3pXUkpSa0xGMWFYQWowbURILXpkTVl5MFhfMTZiV3pybFU3WGh5d2s0UzgwM3V1TmhETkJibnJJbUlSekV4R0ZodW9oNG1idzRCOTIxMi1pdHpRQTJFeWFlR29hcmhSNDVEeWZBZTFQbVZ4Sk5qQjBLeGd3bFZqSWJTSW1Od2FDR1hQWWd4S0xMRGdZVlhzaGY3TzdKT09oWmhuWFRLM3J4UQ?oc=5","date":"2025-10-14","type":"pipeline","source":"The Business Journals","summary":"Kailera Therapeutics secures $600M Series B for obesity drug development - The Business Journals","headline":"Kailera Therapeutics secures $600M Series B for obesity drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbXFKZ0xmUVgzS0ZQQTROSmVXN05uNVd2aXFFSVY5Qi1aYjV3a1BfZGVsNjhGSnU5SVVwQ3R3NDg1RTZKSnlmQ1E0ajhqc0FUc1E3aEtTdGVEQVR1X2tQWEgtSFVTblNNQ1ZpbVhHM1ZrM2pLSFpxTkFneXRfRFNaWmhlZGtjRWtWLVZ5b0pHc2lDeE9vRTZFTEo4ektSYWM?oc=5","date":"2025-06-02","type":"pipeline","source":"Fierce Pharma","summary":"With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B - Fierce Pharma","headline":"With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9SUWJkdmtxclJSWmo4M2IzQVhTMGE1YzFHTjhOX3c0ODVtQ2NPZE9vVzBBcDNQMWExVkktZ3B4cGhvQ19PUkFQekJNSklFN2l6d18w?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"TBIO Stock Price, News & Analysis - Stock Titan","headline":"TBIO Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQOVJCdTE1eHZ5bm4tTWdTTUVTeGJJZGUycm92dkxGZ2lVNjNvcTZXTU03X05jVFlweHVkMXcydVFUdUNFTUFGZ3dwelNmbmE1blM2SGJLSUU5emxVNjJQbEU2M3NPYzhLZXdESjFwTHRZQWlHeEpMM2ZQWFMwd28zczdLRTM1SXRvYkI2RkJINDlPNHJIQ3FGTlZTSGpOc29OOXJRVWdFOXl0Ukk?oc=5","date":"2024-09-27","type":"pipeline","source":"BioSpace","summary":"Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors - BioSpace","headline":"Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxObUoya0lZR0EzOFY1NzBQSnowUW1xbVh1eEFyeEoxdUN4b1Q0Z0JJZGNGa2pjWGpqa1NZc21ZU1dCQjEwZE85M2FCdHVndE5Vc25SeUV1b1VDWEFYRnlxUl85aC1kV0R1OXd5TDF0ZFVHcEZOV3lMMzBvbDRnUDMwVkxjSTlfMTJf?oc=5","date":"2022-04-22","type":"pipeline","source":"Pharma Voice","summary":"From the fringes to the forefront — the mRNA era has taken hold of pharma - Pharma Voice","headline":"From the fringes to the forefront — the mRNA era has taken hold of pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNUkE3SmxpTzNLNW5RbnA0LWlldVEyLUViVllOQlp0bldIVW5ueVY1bXJ1eTlsTHBxZXRia0FfRmVBQloySnVQYURMTFdtN3gyUGdnX0VGRnlVMlhyQUExSjZQUjdQckpOWm1IVW4tZnlabEJnVlo0V0VTZkNPMXI0VUV1NXZVaG8?oc=5","date":"2021-09-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sanofi concludes acquisition of Translate Bio for $3.2bn - Pharmaceutical Technology","headline":"Sanofi concludes acquisition of Translate Bio for $3.2bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFB2WnVDVWM1RXpFckxoZ0twcnd6cXZiQkg0NzVmdUc5MHZQVGxOS3FQeU1ZRlZ1MzlCNkx5dXpzX3ppMDJ2MWc0SHd6NTNsLUdrQl9tclNxb20yY21Sajd1XzdoNVRVVS1hUE1uZnZuUG1rZFBxMFE?oc=5","date":"2021-08-17","type":"deal","source":"Labiotech.eu","summary":"Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology - Labiotech.eu","headline":"Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPYktfZ01tQVNrOHQ3c1l2QkdvZXFlbUQwVUtNUS13Wjd6NmZCbmtyUWxKZGVQcC1DejZkV2dqRDFqd0FIR1lsNElxWVZqZmVXRTBGYlNSa1l2OGJXRldMTHMzS0tkcmxWbFFVYUVIdThlYzVWQ1ZMWV9MNXd2MjdHU0Z2RFo4S3Q3SllHdVNhc2E0VTBmNTBjQTVuS0J0WWFicDZ2M1NqQ0M0U0tTVFFNb2RsMUU?oc=5","date":"2021-08-03","type":"deal","source":"Bloomberg.com","summary":"Sanofi to Buy Translate Bio for $3.2 Billion in mRNA Push - Bloomberg.com","headline":"Sanofi to Buy Translate Bio for $3.2 Billion in mRNA Push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPYmJPMEpYdTNzOW1oTlNuamFiTkdydTk5aFdmLXVMMHc5OGFmbERfN0hMbWd1ZGNZTkxKdjNkTXNuRXNoMnA3Vm0yb2dKMVEyS3JmT3MtVG9Qb25xYXFJN0NYT3RUbm5SX2VYekxOQlJ6VWNQSjZlcC1HSU9YUmU0cXRfdExodmM?oc=5","date":"2021-05-03","type":"pipeline","source":"JD Supra","summary":"The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II) - JD Supra","headline":"The mRNA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}